학술논문
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)
Document Type
Article
Author
James, N.D.; de Bono, J.S.; Clarke, N.W.; Cook, A.; Brawley, C.D.; Diaz-Montana, C.; Gilbert, D.; Gilson, C.; Langley, R.E.; Pugh, C.; Rush, H.; Buckner, M.L.; Parmar, M.K.B.; Sydes, M.R.; Ali, A.; Wylie, J.P.; Hoyle, A.P.; Attard, G.; Chowdhury, S.; Cross, W.R.; Dearnaley, D.P.; Gillessen, S.; Jones, R.J.; Malik, Z.I.; Syndikus, I.; Matheson, D.J.; Millman, R.; Parker, C.C.; Rudman, S.M.; Russell, J.M.; Berthold, D.R.; Mason, M.D.; Ritchie, A.W.S.; Birtle, A.J.; Brock, S.J.; Das, P.; Ford, D.; Gale, J.; Grant, W.; Gray, E.K.; Hoskin, P.; Khan, M.M.; Manetta, C.; McPhail, N.J.; O'Sullivan, J.M.; Parikh, O.; Perna, C.; Pezaro, C.J.; Protheroe, A.S.; Robinson, A.J.; Sheehan, D.J.; Srihari, N.N.; Tanguay, J.S.; Thomas, C.W.; Vengalil, S.; Wagstaff, J.
Source
In: International Journal of Cancer . (International Journal of Cancer, 1 August 2022, 151(3):422-434)
Subject
Language
English
ISSN
10970215
00207136
00207136